wr 1065 has been researched along with Cancer of Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-Josef, E; Chen, J; Ensminger, W; Feng, M; Feng, MR; Knol, JA; Lawrence, TS; Lu, Z; Normolle, DP; Pan, CC; Smith, DE | 1 |
| Chen, J; Lawrence, TS; Lu, Z; Smith, DE | 1 |
1 trial(s) available for wr 1065 and Cancer of Liver
| Article | Year |
|---|---|
A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy.
Topics: Adult; Aged; Amifostine; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Female; Humans; Liver; Liver Neoplasms; Logistic Models; Male; Maximum Tolerated Dose; Mercaptoethylamines; Middle Aged; Organs at Risk; Prospective Studies; Radiation Dosage; Radiation Injuries; Radiation Tolerance; Radiation-Protective Agents; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal | 2012 |
1 other study(ies) available for wr 1065 and Cancer of Liver
| Article | Year |
|---|---|
Determination of WR-1065 in human blood by high-performance liquid chromatography following fluorescent derivatization by a maleimide reagent ThioGlo3.
Topics: Amifostine; Chromatography, High Pressure Liquid; Drug Stability; Humans; Liver Neoplasms; Mercaptoethylamines; Pyrans; Pyrroles; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence | 2005 |